Illumina, Inc. Profile Avatar - Palmy Investing

Illumina, Inc.

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications i…
Medical - Diagnostics & Research
US, San Diego [HQ]
Lobbying · US Senate · Influence

Lobbying Analysis

FY Quarter Lobby Expense [in mil. $] Filing Report Time
2024 3 1 LDA-2 Oct. 17, 2024, 2:59 p.m.
2024 2 6 LDA-2 July 22, 2024, 10:57 p.m.
2024 2 6 LDA-2 July 22, 2024, 10:32 a.m.
2024 2 1 LDA-2 July 16, 2024, 12:53 a.m.
2024 1 6 LDA-2 April 23, 2024, 2:50 a.m.
2024 1 6 LDA-2 April 22, 2024, 8:30 p.m.
2024 1 4 LDA-2 April 19, 2024, 2:16 p.m.
2024 1 1 LDA-2 April 17, 2024, 3:18 p.m.
2023 4 6 LDA-2 Jan. 23, 2024, 4:42 a.m.
2023 4 6 LDA-2 Jan. 22, 2024, 9:32 p.m.
2023 4 6 LDA-2 Jan. 19, 2024, 6:39 p.m.
2023 4 1 LDA-2 Jan. 18, 2024, 7:14 p.m.
End of ILMN's Analysis
CIK: 1110803 CUSIP: 452327109 ISIN: US4523271090 LEI: - UEI: -
Secondary Listings